Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Daishin Chemical Co Ltd (4629)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,500.0 +14.0    +0.94%
01:48:23 - Delayed Data. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3484300003 
  • Volume: 1,200
  • Bid/Ask: 1,486.0 / 1,529.0
  • Day's Range: 1,486.0 - 1,500.0
Daishin Chemical 1,500.0 +14.0 +0.94%

4629 Balance Sheet

 
Featured here, the Balance Sheet for Daishin Chemical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 19135 18683 18466 18854
Cash and Short Term Investments 5162 4925 5869 5722
Cash - - - -
Cash & Equivalents 5162 4925 5869 5705
Short Term Investments - - - 17
Total Receivables, Net 12641 12452 11416 11964
Accounts Receivables - Trade, Net 12641 12452 11416 11876
Total Inventory 1239 1154 1092 1145
Prepaid Expenses - - - 18
Other Current Assets, Total 93 152 89 5
Total Assets 24774 24240 24008 24392
Property/Plant/Equipment, Total - Net 4182 4118 4092 4089
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 70 75 79 82
Long Term Investments 1385 1363 1371 1265
Note Receivable - Long Term - - - 88
Other Long Term Assets, Total 2 1 - 1
Other Assets, Total -11309 -11146 -10235 -10696
Total Current Liabilities 8852 8410 8480 8713
Accounts Payable 7924 7488 7364 7605
Payable/Accrued - - - -
Accrued Expenses 81 161 78 298
Notes Payable/Short Term Debt 300 80 200 -
Current Port. of LT Debt/Capital Leases - - - 36
Other Current liabilities, Total 547 681 838 774
Total Liabilities 9044 8594 8659 8951
Total Long Term Debt - - - 22
Long Term Debt - - - -
Capital Lease Obligations - - - 22
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -108 104 -221 196
Total Equity 15730 15646 15349 15441
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 729 729 729 729
Additional Paid-In Capital 675 675 675 675
Retained Earnings (Accumulated Deficit) 14132 14040 13760 13867
Treasury Stock - Common -12 -12 -12 -12
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 206 214 197 182
Total Liabilities & Shareholders' Equity 24774 24240 24008 24392
Total Common Shares Outstanding 4.58 4.58 4.58 4.58
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4629 Comments

Write your thoughts about Daishin Chemical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email